Depressive Disorder, Major: Clinical Trials

2,985 trials for Depressive Disorder, Major, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1801 completed, 342 recruiting, 320 unknown, 189 terminated. 1163 Not applicable, 508 Phase 2, 437 Phase 3, 333 Phase 4, 211 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable1163Completed 614, Recruiting 179, Unknown 168, Not yet recruiting 69, Terminated 51, Active not recruiting 34, Withdrawn 32, Enrolling by invitation 10, Suspended 6
Phase 2508Completed 326, Recruiting 58, Terminated 48, Unknown 31, Withdrawn 16, Active not recruiting 14, Not yet recruiting 12, Suspended 2, Enrolling by invitation 1
Phase 3437Completed 322, Terminated 38, Recruiting 32, Unknown 14, Withdrawn 13, Active not recruiting 8, Not yet recruiting 7, Suspended 2, Enrolling by invitation 1
Phase 4333Completed 223, Unknown 43, Terminated 27, Recruiting 14, Not yet recruiting 11, Withdrawn 11, Active not recruiting 3, Enrolling by invitation 1
Phase 1211Completed 146, Recruiting 16, Terminated 14, Withdrawn 12, Unknown 11, Active not recruiting 5, Not yet recruiting 5, Enrolling by invitation 2
Early Phase 128Completed 12, Recruiting 4, Unknown 4, Active not recruiting 2, Terminated 2, Withdrawn 2, Enrolling by invitation 1, Not yet recruiting 1

Follow Depressive Disorder, Major: new trials by email Literature Review of Depressive Disorder, Major trials Research Report on Depressive Disorder, Major

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Personalized Pharmaco-Lifestyle Interventions for Severe Mental Illnesses (LIFETRAIN)
Semaglutide (SEMA), Exercise module, Anti-inflammatory diet module - Severe Mental Illness, Depression / Major Depressive Disorder
Not applicableNot yet recruitingLudwig-Maximilians - University of Munich1402028-10-012026-05-14
iMORE+ Study: A Multi-Omics Cohort Study of Major Depressive Disorder
Major Depressive Disorder (MDD)
Not yet recruitingShanghai Mental Health Center1502027-09-012026-08-03
Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder
bupropion hydrobromide, Placebo - Major Depressive Disorder
Phase 4Not yet recruitingBausch Health Americas, Inc.2462027-07-012026-09-29
Evaluation of the Acceptability, Feasibility and Exploration of the Efficacy of an Integrated Care Pathway CARIBOU
CARIBOU Integrated Care Pathway, Treatment as Usual (TAU) - Major Depressive Disorder (MDD)
Not applicableNot yet recruitingUniversidad de los Andes, Chile722027-07-012026-10-20
Stony Brook Medicine Anti-Inflammatory Trial
Celecoxib, Minocycline - Major Depressive Disorder
Phase 4Not yet recruitingStony Brook University422027-06-012026-04-23
CYOA App Intervention for Social Media Use in Adolescents With Depression
Choose Your Own Adventure App - Major Depressive Disorder, Depression
Not applicableNot yet recruitingUniversity of Minnesota602027-06-012026-11-13
A Mobile Health Intervention to Improve Psychosocial Functioning in Veterans With Posttraumatic Stress Disorder and Depression Symptoms
Self-Guided STAIR Coach with Real-Time Assessment, Real-Time Assessment - Psychosocial Functioning, Stress Disorders, Post-Traumatic
Not applicableNot yet recruitingVA Office of Research and Development402027-04-012026-10-06
Role of Kynurenine Pathway and Its Metabolites in Depressive Disorders, Major Depressive Disorder is Suspected to Have the Greatest Burden by 2030,Kynurenine Pathway is Major Route Through Which the Essential Amino Acid Tryptophan is Metabolised and Activated in Time of Stress and Immune Activation.
Major Depressive Disorder (MDD)
Not yet recruitingSohag University902027-03-142026-08-20
A Phase I/II Study of PDC-1421 for Treating Depression in Cancer Patients
PDC-1421 Capsule - Major Depressive Disorder
Phase 1 / Phase 2Not yet recruitingBioLite, Inc.122027-01-152026-04-20
Psilocybin for Depression in Veterans
Psilocybin, modafinil, zolpidem - Major Depression
Phase 2Not yet recruitingVA Office of Research and Development1502027-01-012026-10-26
Brain Network Mechanisms of Cognitive Impairments in Major Psychiatric Disorders and Their Clinical Applications
repetitive transcranial magnetic stimulation (rTMS) - Schizophrenia, Bipolar Disorder
Not applicableNot yet recruitingCentral South University4002027-01-012026-03-04
Augmented Depression Therapy (ADepT) Case Series
Augmented Depression Therapy (ADepT) - Depression / Major Depressive Disorder
Not applicableNot yet recruitingOhio State University402027-01-012026-10-15
Acceptance and Committment Therapy Combined With Ketamine in Difficult-to-Treat Depression.
K-ACT Intervention - Major Depressive Disorder (MDD)
Not applicableNot yet recruitingUniversity of British Columbia502027-01-012026-10-30
Nature-Based Exercise for Major Depressive Disorder
Nature-Based Combined Exercise Program, Indoor Combined Exercise Program, Usual Mental Healthcare and Occupational Activities - Major Depressive Disorder (MDD)
Not applicableNot yet recruitingUniversity of the Basque Country (UPV/EHU)2062027-01-012026-11-12
Assessing of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies
Transcranial Magnetic Stimulation, Psilocybin (drug), Neurofeedback - PTSD, PTSD - Post Traumatic Stress Disorder
Phase 2Not yet recruitingUniversity of New Mexico1502026-12-312026-10-30
Mild-Intensity Whole Body Hyperthermia (WBH) for Major Depressive Disorder
Tocilizumab, Placebo, Whole-Body Hyperthermia - Major Depressive Disorder
Phase 2SuspendedMassachusetts General Hospital352026-12-012025-11-13
Youth Suicide Prevention: CAMS-BI vs. Safety Planning in a Randomized Trial
CAMS Brief Intervention, Stanley-Brown Safety Planning Intervention - Suicidal Ideation, Suicide Attempt
Not applicableNot yet recruitingThe Cleveland Clinic1182026-12-012026-10-07
Accelerated iTBS for Depression and Suicidality
Accelerated Intermittent Theta Burst (aiTBS), Electroconvulsive therapy (ECT) - Major Depressive Disorder, Suicide
Not applicableNot yet recruitingUniversity of Iowa502026-12-012025-05-20
Multi-site Feasibility of an Integrated Treatment for the Biology and Experience of Depression: The MULTIBED Study
Cognitive Behavioral Therapy (CBT), Whole-Body Hyperthermia - Major Depressive Disorder
Not applicableNot yet recruitingUniversity of California, San Francisco602026-12-012026-10-13
Mechanisms of Repeated Real-time Biofeedback With 7-Tesla MRI in Depression
Active Biofeedback, Sham Biofeedback - Major Depressive Disorder (MDD)
Not applicableRecruitingUniversity of Oxford602026-12-012026-11-03

Showing 20 of 2985. Sign in to see all of them.

Narrower conditions

Depression (1066)  ·  Bipolar Disorder (252)  ·  Depressive Disorder (212)  ·  Depressive Disorder, Treatment-Resistant (172)  ·  Anxiety Disorders (137)  ·  Mood Disorders (126)  ·  Schizophrenia (119)  ·  Stress Disorders, Post-Traumatic (85)  ·  Mental Disorders (80)  ·  Psychotic Disorders (71)  ·  Generalized Anxiety Disorder (67)  ·  Suicidal Ideation (56)  ·  Dysthymic Disorder (51)  ·  Recurrence (43)

Broader conditions

Mental Disorders (2905)  ·  Mood Disorders (2859)  ·  Depressive Disorder (2773)  ·  Behavior (1173)  ·  Behavioral Symptoms (1107)  ·  Bipolar and Related Disorders (250)  ·  Pathological Conditions, Signs and Symptoms (229)  ·  Nervous System Diseases (199)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (140)  ·  Signs and Symptoms (132)  ·  Pathologic Processes (111)  ·  Neurologic Manifestations (102)  ·  Trauma and Stressor Related Disorders (92)  ·  Stress Disorders, Traumatic (83)  ·  Self-Injurious Behavior (74)

Interventions

Escitalopram (166)  ·  Transcranial Magnetic Stimulation (110)  ·  Ketamine (108)  ·  Duloxetine Hydrochloride (80)  ·  Sertraline (77)  ·  Cognitive Behavioral Therapy (67)  ·  Vortioxetine (64)  ·  Fluoxetine (62)  ·  Therapeutics (62)  ·  Transcranial Direct Current Stimulation (54)  ·  Bupropion (50)  ·  Venlafaxine Hydrochloride (46)  ·  Selective Serotonin Reuptake Inhibitors (44)  ·  Paroxetine (41)  ·  Citalopram (37)

Sponsors

Massachusetts General Hospital (86)  ·  National Institute of Mental Health (NIMH) (65)  ·  Eli Lilly and Company (58)  ·  New York State Psychiatric Institute (50)  ·  Centre for Addiction and Mental Health (48)  ·  Janssen Research & Development, LLC (38)  ·  Shanghai Mental Health Center (38)  ·  Stanford University (38)  ·  University of California, Los Angeles (37)  ·  Otsuka Pharmaceutical Development & Commercialization, Inc. (36)  ·  H. Lundbeck A/S (34)  ·  AstraZeneca (33)  ·  Mclean Hospital (32)  ·  GlaxoSmithKline (29)  ·  Forest Laboratories (27)

Countries

United States (1478)  ·  Canada (308)  ·  China (193)  ·  Germany (161)  ·  France (126)  ·  Spain (91)  ·  United Kingdom (91)  ·  Poland (82)  ·  Taiwan (68)  ·  Australia (67)  ·  South Korea (67)  ·  Bulgaria (60)  ·  Israel (58)  ·  Russia (56)  ·  Sweden (56)

Top investigators

Maurizio Fava, MD (14)  ·  Carlos A Zarate, M.D. (13)  ·  Jenna Hoogerheyde (11)  ·  Hesheng Liu, Ph.D. (9)  ·  Carl Gommoll, MS (8)

Results publications

PMID 25758058, PMID 34817851, PMID 26644956, PMID 26709542, PMID 34183490, PMID 34510411, PMID 24816198, PMID 29140227, PMID 24067192, PMID 24175720, PMID 24571916, PMID 26474010, PMID 30508090, PMID 27685842, PMID 27780334, PMID 31577867, PMID 31818787, PMID 36708956, PMID 23485955, PMID 23497790, PMID 26644957, PMID 29608461, PMID 32242018, PMID 37656180, PMID 21731833, PMID 22106941, PMID 23106023, PMID 23216998, PMID 23585997, PMID 23585999, PMID 23673347, PMID 24127687, PMID 24766999, PMID 25271445, PMID 27035159, PMID 27488181, PMID 29523415, PMID 30439678, PMID 31087825, PMID 34131914, PMID 34874888, PMID 34894307, PMID 36999619, PMID 37099968, PMID 37585253, PMID 38421922, PMID 38819882, PMID 40607746, PMID 40852147, PMID 41055581

NIH funding

2008 (14), 2018 (9), 2019 (9), 2023 (9), 2025 (9), 2014 (6), 2015 (6), 2016 (6), 2017 (4), 2009 (3), 271201100006I-0-27100007-1 (2), K23MH076049 (2), P20GM113125 (2), R00MH101235 (2), R01MH039188 (2)